1-1 of 1
Markus Galhuber
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Amplification of 1q21 Is Associated with Poor Outcome after Treatment with Bortezomib in Relapsed/Refractory Multiple Myeloma.

Johannes Drach, MD, Verena Sagaster, MD, Victoria Odelga, MD, Hannes Kaufmann, MD, Jutta Ackermann, Markus Galhuber, Niklas Zojer, MD, Elisabeth Küenburg, MD, Christoph Zielinski, MD, Rotraud Wieser, MD, Heinz Ludwig, MD
Journal: Blood
Blood (2006) 108 (11): 3398.
https://doi.org/10.1182/blood.V108.11.3398.3398
Published: 2006